Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 31;13(5):899-901.
doi: 10.21037/tau-23-612. Epub 2024 May 7.

Modifying and personalizing prostate cancer screening

Alexandra Stone  1 , Hanan Goldberg  1
Affiliations
Editorial

Modifying and personalizing prostate cancer screening

Alexandra Stone et al. Transl Androl Urol. .
No abstract available

Keywords: Prostate cancer (PCa); prostate-specific antigen (PSA); risk factors; screening.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-612/coif). H.G. is a speaker for Bayer and Pfizer. The other author has no conflicts of interest to declare.

Comment on

References

    1. Catalona WJ. Prostate Cancer Screening. Med Clin North Am 2018;102:199-214. 10.1016/j.mcna.2017.11.001 - DOI - PMC - PubMed
    1. Ilic D, Djulbegovic M, Jung JH, et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ 2018;362:k3519. 10.1136/bmj.k3519 - DOI - PMC - PubMed
    1. Remmers S, Bangma CH, Godtman RA, et al. Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer. Eur Urol 2023;84:503-9. 10.1016/j.eururo.2023.03.031 - DOI - PMC - PubMed
    1. Carlsson S, Assel M, Sjoberg D, et al. Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study. BMJ 2014;348:g2296. 10.1136/bmj.g2296 - DOI - PMC - PubMed
    1. Preston MA, Batista JL, Wilson KM, et al. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer. J Clin Oncol 2016;34:2705-11. 10.1200/JCO.2016.66.7527 - DOI - PMC - PubMed